| J9271 | Injection, pembrolizumab, 1 mg | 14,000 | $40 | $602K |
| J0897 | Injection, denosumab, 1 mg | 6,720 | $20 | $127.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 540 | $100 | $52.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 650 | $60 | $39.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 340 | $100 | $33.8K |
| Q5108 | Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 240 | $100 | $23K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 2,600 | $10 | $15.6K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 160 | $60 | $9.5K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 20 | $340 | $7.5K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 100 | $60 | $5.4K |